Tag Archives: early detection
Most ovarian cancer diagnosed ‘promptly’
Concerns Australian women with ovarian cancer endure a “long and circuitous” path from their first GP visit to eventual diagnosis have been declared unfounded. A study taking in more than … Continue reading
Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass
Objective We sought to compare the Risk of Malignancy Index (RMI) to the Risk of Ovarian Malignancy Algorithm (ROMA) to predict epithelial ovarian cancer (EOC) in women with a pelvic … Continue reading
Posted in News
Leave a comment
DNA Dilemma: The Full Interview With the FDA on DTC Genetic Tests (Newsweek)
In an interview yesterday, the FDA made some potentially controversial and confusing statements about consumer genetics, an area it’s in the process of deciding how to regulate. I criticize the … Continue reading
Ovarian Cancer Development and Metastasis (Am. J. Pathol.)
The biology of ovarian carcinoma differs from that of hematogenously metastasizing tumors because ovarian cancer cells primarily disseminate within the peritoneal cavity and are only superficially invasive. However, since the … Continue reading
Ovarian Cancer National Alliance Comment on Screening Study
Sunday, June 6, a study will be presented to the American Society of Clinical Oncologists regarding ovarian cancer screening. The study, Authored by Karen Lu, followed more than 3,000 women … Continue reading
Cancer victim wins suit
A jury of six in Waterbury Superior Court on Wednesday awarded $4 million to a New Milford woman and $1 million to her husband for negligence caused by her doctor … Continue reading
Posted in News
Leave a comment
Can a Multimarker Assay Improve Screening for Ovarian Cancer?
Almost three quarters of ovarian cancer cases are diagnosed at advanced stages, making this disease the most lethal gynecologic malignancy in U.S. women. Using sera from a total of 1400 … Continue reading
Autoantibodies against stress-induced phosphoprotein-1 as a novel biomarker candidate for ovarian cancer.
Detection of autoantibodies against tumor-associated antigens (TAA) has recently been shown to be a powerful tool for early detection of various cancers. The aim of this study was to investigate … Continue reading
A Step Forward for Two-Step Screening for Ovarian Cancer
Stage for stage, ovarian cancers and breast cancers carry a similar prognosis—more than 90% of women diagnosed with stage I disease survive at least 5 years, but only 30% of … Continue reading
Development of a Multimarker Assay for Early Detection of Ovarian Cancer
Purpose Early detection of ovarian cancer has great promise to improve clinical outcome. Patients and Methods Ninety-six serum biomarkers were analyzed in sera from healthy women and from patients with … Continue reading
Study Makes Strides in Understanding Ovarian Cancer
Findings may lead to development of screening tests for early detection New understanding about the early stages of ovarian cancer may lead to the development of a new screening test … Continue reading
Development of a Multimarker Assay for Early Detection of Ovarian Cancer (J.Clin Onc)
Purpose: Early detection of ovarian cancer has great promise to improve clinical outcome. Patients and Methods: Ninety-six serum biomarkers were analyzed in sera from healthy women and from patients with … Continue reading
